Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with ...

Peter Akerley, Erdene’s President and CEO stated, “The past year was a period of significant progress for Erdene with the ...

American Century Choice Portfolios posted negative returns in the fourth quarter of 2024. Click here to read the full ...